{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:24:29Z","timestamp":1787505869116,"version":"build-2736575974"},"reference-count":213,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2BX005061"],"award-info":[{"award-number":["IK2BX005061"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM103446"],"award-info":[{"award-number":["P20 GM103446"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The immune system is a potent and interwoven regulator of neuropathology in the central nervous system (CNS). For example, gliomas, neurodegenerative diseases, and autoimmune neuroinflammation all have diverse etiology and pathogenesis. Yet, there are numerous similarities in immunological dysfunction between these neuropathological conditions. Synthesizing this knowledge could inform advanced diagnostics and therapeutic platforms. For instance, detection and precision management of neuroinflammation or blood-brain barrier integrity would be broadly applicable. Understanding the targetable or controllable immune pathways of these disorders and engineering local and systemic interventions are essential for improving disease prognosis. This review integrates and contrasts the biology, detection, and treatment of the aforementioned neuropathologies. First, immunological underpinnings and recent discoveries on the role of innate and adaptive immune cells are discussed. Second, diagnostics that span molecular and nanotechnology-based platforms are detailed for enhanced imaging and screening of neuroinflammation. Last, immunomodulatory therapeutics and the precision of biomaterial platforms for neuroimmune regulation are examined. Within this section on therapeutics, both clinical and experimental approaches are stratified by CNS-localized or systemic mechanism-of-action. Overall, the integration of immunotherapies, biomaterials, advanced drug delivery platforms, and precision medicine will be critical in overcoming current treatment limitations for neuropathology that have few or no therapeutic options.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1677612","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:14:41Z","timestamp":1767935681000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Engineering neuroimmune regulation: biomaterial and nanotechnology platforms for neuropathology diagnosis and targeted immunomodulation"],"prefix":"10.3389","volume":"16","author":[{"given":"Mikayla S.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren G.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9999146","article-title":"Neuroinflammation: an integrating overview of reactive-neuroimmune cell interactions in health and disease","volume":"2021","author":"K\u00f6lliker-Frers","year":"2021","journal-title":"Mediators Inflamm"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/342931","article-title":"Innate immunity and neuroinflammation","volume":"2013","author":"Shastri","year":"2013","journal-title":"Mediators Inflamm"},{"key":"B3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1084\/jem.20180199","article-title":"Immune cells and CNS physiology: Microglia and beyond","volume":"216","author":"Norris","year":"2019","journal-title":"J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00141-6","article-title":"Innate and adaptive immune responses in the CNS","volume":"14","author":"Waisman","year":"2015","journal-title":"Lancet Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00698","article-title":"Microglia and beyond: innate immune cells as regulators of brain development and behavioral function","volume":"9","author":"Lenz","year":"2018","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.07.007","article-title":"The role of astrocytes in CNS inflammation","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl Neurodegener"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","article-title":"Roles of neuropathology-associated reactive astrocytes: a systematic review","volume":"11","author":"Lawrence","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat Neurosci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3390\/cancers14051319","article-title":"Tumor-associated macrophages in gliomas-basic insights and treatment opportunities","volume":"14","author":"Andersen","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e163446","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/ijms19030831","article-title":"The role of macrophages in neuroinflammatory and neurodegenerative pathways of Alzheimer\u2019s disease, amyotrophic lateral sclerosis, and multiple sclerosis: pathogenetic cellular effectors and potential therapeutic targets","volume":"19","author":"Mammana","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/molecules25020291","article-title":"The role of macrophage migration inhibitory factor in Alzheimer\u2032s disease: conventionally pathogenetic or unconventionally protective","volume":"25","author":"Petralia","year":"2020","journal-title":"Molecules"},{"key":"B16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl Neurodegener"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.855776\/full","article-title":"Pre-clinical studies identifying molecular pathways of neuroinflammation in Parkinson\u2019s disease: A systematic review","volume":"14","author":"Fathi","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00282\/full","article-title":"Microglial implication in Parkinson\u2019s disease: loss of beneficial physiological roles or gain of inflammatory functions","volume":"12","author":"Lecours","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"113259","DOI":"10.1016\/j.expneurol.2020.113259","article-title":"Increased activation ability of monocytes from ALS patients","volume":"328","author":"Du","year":"2020","journal-title":"Exp Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/14660820410020286","article-title":"Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells","volume":"5","author":"Graves","year":"2004","journal-title":"Amyotrophic Lateral Sclerosis Other Motor Neuron Disord"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.02.015","article-title":"The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"318","author":"Chu","year":"2018","journal-title":"J Neuroimmunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667705","article-title":"The role of distinct subsets of macrophages in the pathogenesis of MS and the impact of different therapeutic agents on these populations","volume":"12","author":"Radandish","year":"2021","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-023-00393-7","article-title":"Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer\u2019s pathology","volume":"13","author":"Gebril","year":"2024","journal-title":"Transl Neurodegener"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2006.40","article-title":"Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease","volume":"38","author":"Kim","year":"2006","journal-title":"Exp Mol Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson\u2019s disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"key":"B26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/cells14060421","article-title":"Microglia in ALS: insights into mechanisms and therapeutic potential","volume":"14","author":"Bond","year":"2025","journal-title":"Cells"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20132477","article-title":"Differential roles of microglia and monocytes in the inflamed central nervous system","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.751183","article-title":"NK cell-based immunotherapy and therapeutic perspective in gliomas","volume":"11","author":"Pan","year":"2021","journal-title":"Front Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e2107507118","DOI":"10.1073\/pnas.2107507118","article-title":"Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1004885\/full","article-title":"Alzheimer\u2019s disease alters the transcriptomic profile of natural killer cells at single-cell resolution","volume":"13","author":"Qi","year":"2022","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12964-023-01324-9","article-title":"Natural killer cells in the central nervous system","volume":"21","author":"Ning","year":"2023","journal-title":"Cell Commun Signaling"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00505-7","article-title":"The role of natural killer cells in Parkinson\u2019s disease","volume":"52","author":"Earls","year":"2020","journal-title":"Exp Mol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.890816","article-title":"Pathological role of natural killer cells in Parkinson\u2019s disease: A systematic review","volume":"14","author":"Zhang","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1909110117","article-title":"NK cells clear \u03b1-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of \u03b1-synucleinopathy","volume":"117","author":"Earls","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41467-020-15644-8","article-title":"Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis","volume":"11","author":"Garofalo","year":"2020","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12974-025-03347-0","article-title":"Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosis","volume":"22","author":"\u00c1lvarez-S\u00e1nchez","year":"2025","journal-title":"J Neuroinflamm"},{"key":"B37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12883-023-03255-x","article-title":"Role of the immune system in amyotrophic lateral sclerosis. Analysis of the natural killer cells and other circulating lymphocytes in a cohort of ALS patients","volume":"23","author":"Piccoli","year":"2023","journal-title":"BMC Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2020.02.012","article-title":"Natural killer cells in multiple sclerosis: A review","volume":"222","author":"Mimpen","year":"2020","journal-title":"Immunol Lett"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00063\/abstract","article-title":"The role of natural killer cells in multiple sclerosis and their therapeutic implications","volume":"4","author":"Chanvillard","year":"2013","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac055","article-title":"T lymphocytes as dynamic regulators of glioma pathobiology","volume":"24","author":"Cordell","year":"2022","journal-title":"Neuro Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2013.12.004","article-title":"The role of regulatory T-cells in glioma immunology","volume":"119","author":"Ooi","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"B42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0165-5728(01)00496-9","article-title":"Occurrence of T cells in the brain of Alzheimer\u2019s disease and other neurological diseases","volume":"124","author":"Togo","year":"2002","journal-title":"J Neuroimmunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e14548","DOI":"10.1002\/alz.14548","article-title":"Exploring the role of T cells in Alzheimer\u2019s and other neurodegenerative diseases: Emerging therapeutic insights from the T Cells in the Brain symposium","volume":"21","author":"Elyaman","year":"2025","journal-title":"Alzheimer\u2019s Dementia"},{"key":"B44","volume-title":"T Lymphocytes in Parkinson\u2019s Disease JPD","author":"Contaldi","year":"2022"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab103","article-title":"CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"144","author":"Williams","year":"2021","journal-title":"Brain"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab157","article-title":"Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation","volume":"3","author":"Rolfes","year":"2021","journal-title":"Brain Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12974-024-03016-8","article-title":"Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis","volume":"21","author":"Wang","year":"2024","journal-title":"J Neuroinflamm"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adp8109","article-title":"Tissue-resident memory CD4+ T cells infiltrate the CNS in progressive multiple sclerosis and contribute to chronic autoimmunity in mice","volume":"17","author":"Pignata","year":"2025","journal-title":"Sci Transl Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101220-015603","article-title":"B cell function in the tumor microenvironment","volume":"40","author":"Downs-Canner","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-025-04989-z","article-title":"Tumor-infiltrating and circulating B cells mediate local and systemic immunomodulatory mechanisms in Glioblastoma","volume":"172","author":"De Domenico","year":"2025","journal-title":"J Neurooncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"Sabatino","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-220261","article-title":"B lymphocytes in Alzheimer\u2019s disease\u2014A comprehensive review","volume":"88","author":"Plantone","year":"2022","journal-title":"J Alzheimer\u2019s Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson\u2019s disease: what we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5097-3","article-title":"Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes","volume":"256","author":"Naor","year":"2009","journal-title":"J Neurol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e23796","DOI":"10.1096\/fj.202302659R","article-title":"Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis","volume":"38","author":"S\u00eerbulescu","year":"2024","journal-title":"FASEB J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.25927","article-title":"Role of B cells in multiple sclerosis and related disorders","volume":"89","author":"Comi","year":"2021","journal-title":"Ann Neurol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"noz212","DOI":"10.1093\/neuonc\/noz212","article-title":"Immune biology of glioma associated macrophages and microglia: Functional and therapeutic implications","volume":"22","author":"Wei","year":"2019","journal-title":"Neuro-Oncology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12927","article-title":"Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome","volume":"31","author":"Gonz\u00e1lez-Tablas Pimenta","year":"2021","journal-title":"Brain Pathol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1236268","article-title":"Interactions between microglia and glioma in tumor microenvironment","volume":"13","author":"Tao","year":"2023","journal-title":"Front Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1084\/jem.38.2.183","article-title":"Conditions determining the transplantability of tissues in the brain","volume":"38","author":"Murphy","year":"1923","journal-title":"J Exp Med"},{"key":"B64","article-title":"On the transplantation of the rat sarcoma in adult heterogenous animals","volume":"1","author":"Shirai","year":"1921","journal-title":"Jap Med World"},{"key":"B65","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/2347-8659.139717","article-title":"Chronic inflammation drives glioma growth: cellular and molecular factors responsible for an immunosuppressive microenvironment","volume":"1","author":"Ha","year":"2014","journal-title":"Neurosciences"},{"key":"B66","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12964-023-01255-5","article-title":"Dysregulation of inflammasome activation in glioma","volume":"21","author":"Sim","year":"2023","journal-title":"Cell Commun Signaling"},{"key":"B67","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.3390\/cancers13164226","article-title":"Role of inflammatory mediators, macrophages, and neutrophils in glioma maintenance and progression: mechanistic understanding and potential therapeutic applications","volume":"13","author":"Basheer","year":"2021","journal-title":"Cancers"},{"key":"B68","doi-asserted-by":"publisher","first-page":"151853","DOI":"10.1016\/j.imbio.2019.10.002","article-title":"Role of myeloid cells in the immunosuppressive microenvironment in gliomas","volume":"225","author":"Locarno","year":"2020","journal-title":"Immunobiology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1123853","article-title":"Glioma-associated microglia\/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy","volume":"14","author":"Lin","year":"2023","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.964898","article-title":"Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19994","article-title":"M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma","volume":"8","author":"Leblond","year":"2017","journal-title":"Oncotarget"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00835","article-title":"Single-cell atlas reveals complexity of the immunosuppressive microenvironment of initial and recurrent glioblastoma","volume":"11","author":"Fu","year":"2020","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.3390\/ijms23084166","article-title":"Systematic review on tumor microenvironment in glial neoplasm: from understanding pathogenesis to future therapeutic perspectives","volume":"23","author":"Bianconi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-024-03222-4","article-title":"Microenvironmental regulation of tumor-associated neutrophils in Malignant glioma: from mechanism to therapy","volume":"21","author":"Wen","year":"2024","journal-title":"J Neuroinflamm"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1393173","article-title":"Neutrophils in glioma microenvironment: from immune function to immunotherapy","volume":"15","author":"Sun","year":"2024","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","article-title":"Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy","volume":"24","author":"He","year":"2025","journal-title":"Mol Cancer"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1355","article-title":"Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner","volume":"10","author":"Bayik","year":"2020","journal-title":"Cancer Discov"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac138","article-title":"Dysfunctional dendritic cells limit antigen-specific T cell response in glioma","volume":"25","author":"Friedrich","year":"2023","journal-title":"Neuro-Oncology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-021-03822-7","article-title":"Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner","volume":"154","author":"Noffsinger","year":"2021","journal-title":"J Neurooncol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00652-6","article-title":"B cells in central nervous system disease: diversity, locations and pathophysiology","volume":"22","author":"Jain","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.881427","article-title":"Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity","volume":"13","author":"Qin","year":"2022","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11060-020-03483-y","article-title":"Immune suppression in gliomas","volume":"151","author":"Grabowski","year":"2021","journal-title":"J Neurooncol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0240","article-title":"Myeloid-derived suppressive cells promote B cell\u2013mediated immunosuppression via transfer of PD-L1 in glioblastoma","volume":"7","author":"Lee-Chang","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-021-00465-0","article-title":"Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology","volume":"16","author":"Rahman","year":"2021","journal-title":"Mol Neurodegener"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3887","article-title":"Spreading of pathology in neurodegenerative diseases: a focus on human studies","volume":"16","author":"Brettschneider","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1575453","article-title":"The roles of microglia and astrocytes in neuroinflammation of Alzheimer\u2019s disease","volume":"19","author":"Han","year":"2025","journal-title":"Front Neurosci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02122","article-title":"Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer\u2019s disease, Parkinson\u2019s disease and amyotrophic lateral sclerosis: A systematic review and meta-analysis","volume":"9","author":"Chen","year":"2018","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"B92","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","article-title":"Blood\u2013brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy","volume":"13","author":"Lau","year":"2024","journal-title":"Trans Neurodegener"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-024-01775-4","article-title":"Modeling Parkinson\u2019s disease pathology in human dopaminergic neurons by sequential exposure to \u03b1-synuclein fibrils and proinflammatory cytokines","volume":"27","author":"Bayati","year":"2024","journal-title":"Nat Neurosci"},{"key":"B94","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/d41573-025-00093-z","article-title":"Lowering pathological \u03b1-synuclein","volume":"24","author":"Crunkhorn","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2014.05.015","article-title":"Glial cells in amyotrophic lateral sclerosis","author":"Philips","year":"2014","journal-title":"Exp Neurol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.851563","article-title":"Breached barriers: A scoping review of blood-central nervous system barrier pathology in amyotrophic lateral sclerosis","volume":"16","author":"Mirian","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.3390\/ijms26083854","article-title":"Neuroinflammation and amyotrophic lateral sclerosis: recent advances in anti-inflammatory cytokines as therapeutic strategies","volume":"26","author":"Stacchiotti","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.890958","article-title":"Neuroimmune crosstalk between the peripheral and the central immune system in amyotrophic lateral sclerosis","volume":"14","author":"Yu","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"B101","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e38086","DOI":"10.1097\/MD.0000000000038086","article-title":"Neuroinflammation in dementia: A meta-analysis of PET imaging studies","volume":"103","author":"Pan","year":"2024","journal-title":"Med (Baltimore)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20919","article-title":"Extracellular mutant SOD1 induces microglial-mediated motoneuron injury","volume":"58","author":"Zhao","year":"2010","journal-title":"Glia"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa309","article-title":"Microglial component of amyotrophic lateral sclerosis","volume":"143","author":"Clarke","year":"2020","journal-title":"Brain"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/biom14101204","article-title":"Astrocyte-mediated neuroinflammation in neurological conditions","volume":"14","author":"Zhao","year":"2024","journal-title":"Biomolecules"},{"key":"B106","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40035-021-00265-y","article-title":"Astrocyte dysfunction in Parkinson\u2019s disease: from the perspectives of transmitted \u03b1-synuclein and genetic modulation","volume":"10","author":"Wang","year":"2021","journal-title":"Trans Neurodegener"},{"key":"B107","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13024-024-00773-1","article-title":"Human VCP mutant ALS\/FTD microglia display immune and lysosomal phenotypes independently of GPNMB","volume":"19","author":"Clarke","year":"2024","journal-title":"Mol Neurodegener"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-023-01415-3","article-title":"Infiltrating CD8+ T cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model","volume":"26","author":"Jorfi","year":"2023","journal-title":"Nat Neurosci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","article-title":"Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease","volume":"577","author":"Gate","year":"2020","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36470","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J Clin Invest"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr074","article-title":"Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis","volume":"134","author":"Beers","year":"2011","journal-title":"Brain"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2004.10.009","article-title":"Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS)","volume":"159","author":"Zhang","year":"2005","journal-title":"J Neuroimmunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"20587392211039935","DOI":"10.1177\/20587392211039935","article-title":"Low-dose IL-2 in the treatment of immune-related diseases","volume":"19","author":"Zhang","year":"2021","journal-title":"Eur J Inflamm"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.648408\/full","article-title":"Low-dose IL-2 therapy in autoimmune and rheumatic diseases","volume":"12","author":"Gra\u00dfhoff","year":"2021","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2024.2330642","article-title":"Immunopathogenesis of multiple sclerosis: molecular and cellular mechanisms and new immunotherapeutic approaches","volume":"46","author":"Aliyu","year":"2024","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.008","article-title":"Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting","volume":"186","author":"Charabati","year":"2023","journal-title":"Cell"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac389","article-title":"MCAM+ brain endothelial cells contribute to neuroinflammation by recruiting pathogenic CD4+ T lymphocytes","volume":"146","author":"Charabati","year":"2023","journal-title":"Brain"},{"key":"B119","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12974-015-0346-0","article-title":"Pro-inflammatory TNF\u03b1 and IL-1\u03b2 differentially regulate the inflammatory phenotype of brain microvascular endothelial cells","volume":"12","author":"O'Carroll","year":"2015","journal-title":"J Neuroinflamm"},{"key":"B120","article-title":"Immunopathogenesis of multiple sclerosis","volume":"61","author":"Garg","year":"2019","journal-title":"Practical Neurology"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430405","article-title":"Epilepsies in twins: Genetics of the major epilepsy syndromes","volume":"43","author":"Berkovic","year":"1998","journal-title":"Ann Neurol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12974-024-03326-x","article-title":"Microglia and Immune cells interactions in multiple sclerosis cognitive impairment: a postmortem study","volume":"21","author":"Barros","year":"2024","journal-title":"J Neuroinflamm"},{"key":"B123","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12974-022-02408-y","article-title":"Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics","volume":"19","author":"Kamma","year":"2022","journal-title":"J Neuroinflamm"},{"key":"B124","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40478-021-01306-3","article-title":"Brain macrophages acquire distinct transcriptomes in multiple sclerosis lesions and normal appearing white matter","volume":"10","author":"Miedema","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"B125","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/cells9020482","article-title":"T helper cells: the modulators of inflammation in multiple sclerosis","volume":"9","author":"Kunkl","year":"2020","journal-title":"Cells"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers","volume":"11","author":"Van Langelaar","year":"2020","journal-title":"Front Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2013.815726","article-title":"CD8+ T cells in multiple sclerosis","volume":"17","author":"Denic","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00454-2","article-title":"Rethinking peripheral T cell tolerance: checkpoints across a T cell\u2019s journey","volume":"21","author":"ElTanbouly","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-018-1709-7","article-title":"Antigen-presenting cell diversity for T cell reactivation in central nervous system autoimmunity","volume":"96","author":"Waisman","year":"2018","journal-title":"J Mol Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12935-023-02947-1","article-title":"Recent advances in the detection of glioblastoma, from imaging-based methods to proteomics and biosensors: A narrative review","volume":"23","author":"Hosseini","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B132","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/curroncol32010016","article-title":"Understanding the immune system and biospecimen-based response in glioblastoma: A practical guide to utilizing signal redundancy for biomarker and immune signature discovery","volume":"32","author":"Jackson","year":"2025","journal-title":"Curr Oncol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/brainsci14070687","article-title":"Neuroinflammation in glioblastoma: progress and perspectives","volume":"14","author":"Li","year":"2024","journal-title":"Brain Sci"},{"key":"B134","doi-asserted-by":"publisher","first-page":"9842","DOI":"10.3390\/s23249842","article-title":"Advances in diagnostic tools and therapeutic approaches for gliomas: A comprehensive review","volume":"23","author":"Thenuwara","year":"2023","journal-title":"Sensors"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdac036","article-title":"Prediagnostic biomarkers for early detection of glioma\u2014using case\u2013control studies from cohorts as study approach","volume":"4","author":"Wu","year":"2022","journal-title":"Neuro Oncol Adv"},{"key":"B136","doi-asserted-by":"publisher","first-page":"14283","DOI":"10.1038\/s41598-025-97943-y","article-title":"Enhanced detection of glioblastoma vasculature with superparamagnetic iron oxide nanoparticles and MRI","volume":"15","author":"Janowicz","year":"2025","journal-title":"Sci Rep"},{"key":"B137","doi-asserted-by":"publisher","first-page":"e37376","DOI":"10.1371\/journal.pone.0037376","article-title":"Conjugation of functionalized SPIONs with transferrin for targeting and imaging brain glial tumors in rat model","volume":"7","author":"Jiang","year":"2012","journal-title":"PloS One"},{"key":"B138","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.biomaterials.2010.09.024","article-title":"Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo","volume":"32","author":"Xie","year":"2011","journal-title":"Biomaterials"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.29399\/npa.28312","article-title":"Biomarker value of neurofilaments and glial fibrillary acidic protein in central nervous system lymphoma and tumors","volume":"59","author":"Y\u00fcceer","year":"2022","journal-title":"Noro Psikiyatr Ars"},{"key":"B140","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12014-024-09492-7","article-title":"Glial fibrillary acidic protein, neurofilament light, matrix metalloprotease 3 and fatty acid binding protein 4 as non-invasive brain tumor biomarkers","volume":"21","author":"Ghorbani","year":"2024","journal-title":"Clin Proteom"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww017","article-title":"Early and protective microglial activation in Alzheimer\u2019s disease: a prospective study using 18 F-DPA-714 PET imaging","volume":"139","author":"Hamelin","year":"2016","journal-title":"Brain"},{"key":"B142","doi-asserted-by":"publisher","first-page":"45S","DOI":"10.2967\/jnumed.121.263200","article-title":"Imaging neuroinflammation in neurodegenerative disorders","volume":"63","author":"Masdeu","year":"2022","journal-title":"J Nucl Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.3390\/ijms20133161","article-title":"Recent developments in TSPO PET imaging as A biomarker of neuroinflammation in neurodegenerative disorders","volume":"20","author":"Werry","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1487-12.2012","article-title":"Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging","volume":"32","author":"Lavisse","year":"2012","journal-title":"J Neurosci"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-025-02939-9","article-title":"Neuroinflammatory fluid biomarkers in patients with Alzheimer\u2019s disease: a systematic literature review","volume":"30","author":"Heneka","year":"2025","journal-title":"Mol Psychiatry"},{"key":"B146","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.3390\/pharmaceutics14112545","article-title":"18F-radiolabeled translocator protein (TSPO) PET tracers: recent development of TSPO radioligands and their application to PET study","volume":"14","author":"Luu","year":"2022","journal-title":"Pharmaceutics"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2024.09.007","article-title":"Emerging TSPO-PET radiotracers for imaging neuroinflammation: A critical analysis","volume":"54","author":"Cumbers","year":"2024","journal-title":"Semin Nucl Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.231340","article-title":"Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of worsening disability in multiple sclerosis","volume":"61","author":"Bodini","year":"2020","journal-title":"J Nucl Med"},{"key":"B149","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12974-018-1352-9","article-title":"In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET","volume":"15","author":"Hagens","year":"2018","journal-title":"J Neuroinflamm"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.7150\/thno.32461","article-title":"Molecular imaging of immune cell dynamics during de- and remyelination in the cuprizone model of multiple sclerosis by [18 F]DPA-714 PET and MRI","volume":"9","author":"Zinnhardt","year":"2019","journal-title":"Theranostics"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26657","article-title":"Positron emission tomography with [18 F]-DPA-714 unveils a smoldering component in most multiple sclerosis lesions which drives disease progression","volume":"94","author":"Hamzaoui","year":"2023","journal-title":"Ann Neurol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti\u2013myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes","volume":"77","author":"Waters","year":"2020","journal-title":"Pediatrics"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.oa.2021-0024","article-title":"Safety of gliadel implant for Malignant glioma: report of postmarketing surveillance in Japan","volume":"61","author":"Nishikawa","year":"2021","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"B156","doi-asserted-by":"publisher","first-page":"vdab189","DOI":"10.1093\/noajnl\/vdab189","article-title":"Long-term effectiveness of Gliadel implant for Malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan","volume":"4","author":"Iuchi","year":"2022","journal-title":"Neuro Oncol Adv"},{"key":"B157","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0168-3659(96)01371-5","article-title":"Effects of GLIADEL\u00ae wafer initial molecular weight on the erosion of wafer and release of BCNU","volume":"42","author":"Dang","year":"1996","journal-title":"J Controlled Release: Off J Controlled Release Society"},{"key":"B158","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/ph18030376","article-title":"A 5-year update on the clinical development of cancer cell-based vaccines for glioblastoma multiforme","volume":"18","author":"Alkayyal","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B159","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12672-024-01229-0","article-title":"The interplay between metal ions and immune cells in glioma: pathways to immune escape","volume":"15","author":"Li","year":"2024","journal-title":"Discov Onc"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2733-0","article-title":"Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system","volume":"137","author":"Shibahara","year":"2018","journal-title":"J Neurooncol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41598-022-27128-4","article-title":"The clinical significance of radiological changes associated with gliadel implantation in patients with recurrent high grade glioma","volume":"13","author":"Haim","year":"2023","journal-title":"Sci Rep"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2020.05.012","article-title":"Development and in vivo evaluation of Irinotecan-loaded Drug Eluting Seeds (iDES) for the localised treatment of recurrent glioblastoma multiforme","volume":"324","author":"Gawley","year":"2020","journal-title":"J Controlled Release"},{"key":"B163","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.3390\/cancers16173008","article-title":"Local delivery of irinotecan to recurrent GBM patients at reoperation offers a safe route of administration","volume":"16","author":"McConville","year":"2024","journal-title":"Cancers"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac200.003","article-title":"ChemoSeed\u00ae: A novel implantable device for the treatment of high grade gliomas","volume":"24","author":"Abdelnabi","year":"2022","journal-title":"Neuro-Oncology"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2011.03.019","article-title":"Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications","volume":"85","author":"Schant\u00e9","year":"2011","journal-title":"Carbohydr Polym"},{"key":"B166","doi-asserted-by":"publisher","first-page":"17811","DOI":"10.1038\/s41598-025-02977-x","article-title":"GliaTrap is a biodegradable, non-swelling and non-inflammatory hydrogel with tuned release of CXCL12 to attract migrating glioblastoma cells","volume":"15","author":"Suita","year":"2025","journal-title":"Sci Rep"},{"key":"B167","article-title":"The response of immune sentinels causing inflammation in glioma and glioblastoma","volume":"12","author":"D\u2019Ovidio","year":"2023","journal-title":"Eur J Neurodegener Dis"},{"key":"B168","doi-asserted-by":"publisher","first-page":"105527","DOI":"10.1101\/2023.04.12.536581v1","article-title":"Engineering GliaTrap: a biodegradable non-swelling hydrogel with tuned release of CXCL12 to attract migrating glioblastoma cells","volume":"95","author":"Suita","year":"2023","journal-title":"bioRxiv"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1042\/NS20210028","article-title":"Anti-inflammatory cytokine-eluting collagen hydrogel reduces the host immune response to dopaminergic cell transplants in a rat model of Parkinson\u2019s disease","volume":"5","author":"Cabr\u00e9","year":"2021","journal-title":"Neuronal Signal"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2024.05.006","article-title":"Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer\u2019s disease","volume":"119","author":"Badr","year":"2024","journal-title":"Brain Behav Immun"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1039\/D4BM01566E","article-title":"An immunomodulatory encapsulation system to deliver human iPSC-derived dopaminergic neuron progenitors for Parkinson\u2019s disease treatment","volume":"13","author":"Atkinson","year":"2025","journal-title":"Biomater Sci"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.37118","article-title":"Localized hydrogel delivery of dendritic cells for attenuation of multiple sclerosis in a murine model","volume":"109","author":"Thomas","year":"2021","journal-title":"J Biomed Mater Res"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.2c00465","article-title":"IL-10-functionalized hydrogels support immunosuppressive dendritic cell phenotype and function","volume":"8","author":"Beskid","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1039\/D4MH01598C","article-title":"Hyaluronic acid-based hydrogels modulate neuroinflammation and extracellular matrix remodelling in multiple sclerosis: insights from a primary cortical cell model","volume":"12","author":"Martin-Salda\u00f1a","year":"2025","journal-title":"Mater Horizons"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.08.057","article-title":"Microneedle-mediated vascular endothelial growth factor delivery promotes angiogenesis and functional recovery after stroke","volume":"338","author":"Liu","year":"2021","journal-title":"J Controlled Release"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1021\/nn405033r","article-title":"A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease","volume":"8","author":"Hunter","year":"2014","journal-title":"ACS Nano"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1408686111","article-title":"Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance","volume":"112","author":"Maldonado","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B178","doi-asserted-by":"publisher","first-page":"8866","DOI":"10.3390\/ijms22168866","article-title":"Multiple sclerosis: focus on extracellular and artificial vesicles, nanoparticles as potential therapeutic approaches","volume":"22","author":"Nuzzo","year":"2021","journal-title":"IJMS"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.2c00277","article-title":"Development of PLGA nanoparticles with a glycosylated myelin oligodendrocyte glycoprotein epitope (MOG35\u201355) against experimental autoimmune encephalomyelitis (EAE)","volume":"19","author":"Triantafyllakou","year":"2022","journal-title":"Mol Pharmaceutics"},{"key":"B180","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jneuroim.2019.01.007","article-title":"Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis","volume":"327","author":"Dolati","year":"2019","journal-title":"J Neuroimmunol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1038\/s41467-022-35263-9","article-title":"Immunosuppressive biomaterial-based therapeutic vaccine to treat multiple sclerosis via re-establishing immune tolerance","volume":"13","author":"Nguyen","year":"2022","journal-title":"Nat Commun"},{"key":"B182","doi-asserted-by":"publisher","first-page":"eaaw9668","DOI":"10.1126\/scitranslmed.aaw9668","article-title":"Modular immune-homeostatic microparticles promote immune tolerance in mouse autoimmune models","volume":"13","author":"Chen","year":"2021","journal-title":"Sci Transl Med"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of clinical and MRI features, diagnosis, and management","volume":"13","author":"Sechi","year":"2022","journal-title":"Front Neurol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1137998","article-title":"Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease","volume":"14","author":"Corbali","year":"2023","journal-title":"Front Neurol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S359114","article-title":"Nanoformulated recombinant human myelin basic protein and rituximab modulate neuronal perturbations in experimental autoimmune encephalomyelitis in mice","author":"Saad","year":"2022","journal-title":"Int J Nanomed"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad373","article-title":"Interferon-\u03b3 controls aquaporin 4-specific Th17 and B cells in neuromyelitis optica spectrum disorder","volume":"147","author":"Arellano","year":"2023","journal-title":"Brain"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c02249","article-title":"Albumin-based nanotheranostic probe with hypoxia alleviating potentiates synchronous multimodal imaging and phototherapy for glioma","volume":"14","author":"Yang","year":"2020","journal-title":"ACS Nano"},{"key":"B188","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1038\/s41467-020-19225-7","article-title":"Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy","volume":"11","author":"Gregory","year":"2020","journal-title":"Nat Commun"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.680021","article-title":"Targeting neuroinflammation in brain cancer: uncovering mechanisms, pharmacological targets, and neuropharmaceutical developments","volume":"12","author":"Alghamri","year":"2021","journal-title":"Front Pharmacol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12951-022-01731-z","article-title":"Biomimetic calcium carbonate nanoparticles delivered IL-12 mRNA for targeted glioblastoma sono-immunotherapy by ultrasound-induced necroptosis","volume":"20","author":"Zhao","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1910691","DOI":"10.1002\/adfm.201910691","article-title":"A conditionally releasable \u201cDo not eat me\u201d CD47 signal facilitates microglia-targeted drug delivery for the treatment of Alzheimer\u2019s disease","volume":"30","author":"Zhang","year":"2020","journal-title":"Adv Funct Mater"},{"key":"B192","doi-asserted-by":"publisher","first-page":"119752","DOI":"10.1016\/j.biomaterials.2019.119752","article-title":"Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient neuroprotection through M1\/M2 microglial polarization in an Alzheimer\u2019s disease model","volume":"232","author":"Ren","year":"2020","journal-title":"Biomaterials"},{"key":"B193","doi-asserted-by":"publisher","first-page":"130ra46","DOI":"10.1126\/scitranslmed.3003162","article-title":"Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model","volume":"4","author":"Kannan","year":"2012","journal-title":"Sci Trans Med"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12521","article-title":"Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsingremitting multiple sclerosis in the randomized ADVANCE study","volume":"79","author":"Hu","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"1756286418795085","DOI":"10.1177\/1756286418795085","article-title":"Peginterferon \u03b2-1a every 2 weeks increased achievement of no evidence of disease activity over 4 years in the ADVANCE and ATTAIN studies in patients with relapsing\u2013remitting multiple sclerosis","volume":"11","author":"Arnold","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"B196","doi-asserted-by":"publisher","first-page":"103350","DOI":"10.1016\/j.msard.2021.103350","article-title":"Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in the real-world setting: Interim results from the Plegridy Observational Program","volume":"57","author":"Salvetti","year":"2022","journal-title":"Multiple Sclerosis Relat Disord"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0227-1","article-title":"Peginterferon beta-1a: A review of its use in patients with relapsing-remitting multiple sclerosis","volume":"29","author":"Hoy","year":"2015","journal-title":"CNS Drugs"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c97d99","article-title":"Interferon-\u03b2 mechanisms of action in multiple sclerosis","volume":"74","author":"Dhib-Jalbut","year":"2010","journal-title":"Neurology"},{"key":"B199","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/psb.1387","article-title":"Plegridy for the treatment of RRMS in adults: NEW PRODUCTS","volume":"26","author":"Chaplin","year":"2015","journal-title":"Prescriber"},{"key":"B200","doi-asserted-by":"publisher","first-page":"20552173241238632","DOI":"10.1177\/20552173241238632","article-title":"Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program","volume":"10","author":"Salvetti","year":"2024","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.08.033","article-title":"Reprogramming the local lymph node microenvironment promotes tolerance that is systemic and antigen specific","volume":"16","author":"Tostanoski","year":"2016","journal-title":"Cell Rep"},{"key":"B202","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41467-023-36225-5","article-title":"Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantation","volume":"14","author":"Gammon","year":"2023","journal-title":"Nat Commun"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c07440","article-title":"Exploiting rational assembly to map distinct roles of regulatory cues during autoimmune therapy","volume":"15","author":"Oakes","year":"2021","journal-title":"ACS Nano"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c06667","article-title":"Engineered immune constructs alter antigen-specific immune tolerance and confer durable protection in myelin-driven autoimmunity","volume":"18","author":"Ackun-Farmmer","year":"2024","journal-title":"ACS Nano"},{"key":"B205","doi-asserted-by":"publisher","first-page":"e2409563122","DOI":"10.1073\/pnas.2409563122","article-title":"Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunity","volume":"122","author":"Kapnick","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2018.10.001","article-title":"Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles","volume":"18","author":"Pearson","year":"2019","journal-title":"Nanomedicine"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2434","article-title":"Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis","volume":"30","author":"Getts","year":"2012","journal-title":"Nat Biotechnol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603039","article-title":"Nanoparticle-induced complement activation: implications for cancer nanomedicine","volume":"11","author":"La-Beck","year":"2021","journal-title":"Front Immunol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties of engineered nanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nat Nanotechnol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1039\/D0BM00558D","article-title":"The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives","volume":"8","author":"Foulkes","year":"2020","journal-title":"Biomater Sci"},{"key":"B211","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10856-025-06947-7","article-title":"Biomaterials for CNS disorders: a review of development from traditional methods to AI-assisted optimization","volume":"36","author":"Haramshahi","year":"2025","journal-title":"J Mater Sci: Mater Med"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1039\/d5ra03578c","article-title":"Precision targeting of the CNS: recent progress in brain-directed nanodrug delivery","volume":"15","author":"Senanayake","year":"2025","journal-title":"RSC Adv"},{"key":"B213","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: Structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct Target Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1677612\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:14:43Z","timestamp":1767935683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1677612\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":213,"alternative-id":["10.3389\/fimmu.2025.1677612"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1677612","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"1677612"}}